ĚěĂŔ´ŤĂ˝

Trusted by:

clients clients clients clients clients clients clients clients clients clients
Released: 5-Feb-2025 7:35 PM EST
Innovative program helps seniors manage stress
Universite de Montreal

A new study shows significant long-term reductions in the stress hormone cortisol in seniors taking part in the O’stress program.

Newswise: Timing Matters: Early Planting Benefits Soybean in Unfertilized, Low-Fertility Fields
Released: 5-Feb-2025 7:15 PM EST
Timing Matters: Early Planting Benefits Soybean in Unfertilized, Low-Fertility Fields
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

Unfertilized soybean fields with lower soil fertility should be planted earlier than high fertility fields, according to a University of Illinois Urbana-Champaign study that re-evaluates longtime soil testing. This result comes as a bit of a surprise, says Fred Below, senior author of the study.

4-Feb-2025 9:30 PM EST
Is CBD use during pregnancy as safe as people think? New study uncovers potential risks to babies
McMaster University

Cannabidiol (CBD), the component in cannabis often used for therapeutic treatments, is increasingly being used during pregnancy as a means of managing symptoms such as nausea, anxiety and sleep.

Newswise: 1920_thryroid-cancer-cedars-sinai.jpg?10000
31-Jan-2025 5:50 AM EST
Study: Thyroid Cancer Still Overdiagnosed
Cedars-Sinai

EMBARGOED: A study led by Cedars-Sinai investigators provides new evidence that thyroid cancer continues to be overdiagnosed and that aggressive screening and treatment of thyroid cancer has not led to higher survival rates.

Newswise: Hybrid job training improves participation for women in Nepal, study finds
Release date: 5-Feb-2025 5:35 PM EST
Hybrid job training improves participation for women in Nepal, study finds
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

Globally, women’s workforce participation is about 25% lower than men’s, often due to barriers such as domestic responsibilities and cultural norms. A new study from an international research team explored whether hybrid distance learning can improve accessibility to job training for rural women in Nepal.

4-Feb-2025 9:00 PM EST
AI Tool Helps Find Life-Saving Medicine for Rare Disease
Perelman School of Medicine at the University of Pennsylvania

Set to enter hospice care, a patient with idiopathic multicentric Castleman’s disease is now in remission after treatment with a medication identified by an AI-guided analysis

Newswise: UAH researcher looks to AI and neural networks to reduce wait times for lesion classification in breast cancer patients
Release date: 5-Feb-2025 4:25 PM EST
UAH researcher looks to AI and neural networks to reduce wait times for lesion classification in breast cancer patients
University of Alabama Huntsville

One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting to get test results back, waiting to learn the outcome of treatment protocols. Now a researcher at The University of Alabama in Huntsville (UAH) is co-author of a paper in Nature Scientific Reports that studies the use of artificial intelligence (AI) and neuronal networks to significantly cut the time required for medical professionals to classify lesions in breast cancer ultrasound images.

30-Jan-2025 8:30 PM EST
Black, Hispanic Kids Less Likely to Get Migraine Diagnosis in ER
American Academy of Neurology (AAN)

Children and young people who are Black or Hispanic are less likely to be diagnosed with migraine than those who are white when being seen for headache in a pediatric emergency department, according to a study published in the February 5, 2025, online issue of NeurologyÂŽ, the medical journal of the American Academy of Neurology. The study also found they received fewer tests and less intensive treatment.

Newswise: Cancer Vaccine Shows Promise for Patients with Stage III and IV Kidney Cancer
Released: 5-Feb-2025 11:30 AM EST
Cancer Vaccine Shows Promise for Patients with Stage III and IV Kidney Cancer
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

Released: 5-Feb-2025 11:25 AM EST
Personalized Therapeutic Vaccine ‘Steers’ the Immune System to Fight Kidney Cancer
Yale Cancer Center/Smilow Cancer Hospital

Personalized cancer vaccines (PCVs) train the body’s immune system to recognize and destroy a threat. In this trial, all nine patients who received multiple doses of the vaccine had an immune response within a three-week period and cancer fighting T cells remained elevated for the duration of the study and for years afterward.


close
1.22449